Accurate measurement of cognitive function is essential to research on cognitive aging and Alzheimer's disease (AD). Traditional measurement approaches rely on objective (performance based) and subjective (self-report) assessments of cognition made in clinic or interview settings on a single occasion. Unmeasured sources of within-person variability, retrospective reporting biases and the artificial nature of standard testing environments negatively impact test reliability, measurement accuracy, and ecological validity of standard approaches to cognitive assessment. These problems impede the sensitive measurement of cognitive change and delay detection of clinical conditions, such as amnestic mild cognitive impairment (aMCI) and AD. The overall objective of this application is to develop methods to measure cognitive function of older adults in their daily lives in order to improve the reliability, accuracy, and ecological validity of cognitive measurements. Through these methods, this study will better characterize and identify predictors of the short-term variability and change associated with cognitive aging and dementia risk. The central hypothesis is that repeated ambulatory assessments in daily life will improve the reliability, accuracy and sensitivity of both subjective and objective cognitive measures. The rationale for the proposed research is that the development of more precise and ecologically valid instruments will improve the detection of persons at risk for AD and measurement of treatment effects in clinical trials. Guided by preliminary work using these ambulatory assessments in younger samples and using the repeated measurement burst design to predict cognitive decline, the following specific aims are extended: 1) Test the hypotheses that repeated ambulatory assessments will improve the reliability and accuracy of subjective reports of cognitive function and predict incident aMCI and neuroimaging markers of AD, 2) Test that repeated ambulatory assessments of objective cognitive performance will be more reliable and sensitive for measuring change than conventional in-lab assessments, and that ambulatory memory function will predict transitions to aMCI and neuroimaging markers of AD, 3) Test daily stress as a predictor of worse objective and subjective ambulatory cognitive performance and that this effect is mediated by stress- induced worry and alterations in cardiac autonomic function, 4) Test that individuals whose cognitive performance is more affected by daily stress will have increased risk for cognitive decline and aMCI. The approach is innovative in its use of ambulatory methods to measure real-time determinants of cognitive function in daily life. The research is significant because it will improve the precision, reliability, and ecological validity of methods used to monitor changes in cognitive function. The long-term goal of this work is to develop assessments tools that advance the next generation of early intervention and prevention studies to slow or prevent cognitive decline and progression of AD.

Public Health Relevance

Identification of modifiable risk factors prior to the development of Alzheimer's disease (AD) in old age represents a critical challenge for developing effective treatment and preventive measures, controlling health care costs, and ultimately improving the quality of life for seniors and their families. The proposed research will significantly advance these efforts by developing innovative ambulatory methods that rely on mobile and sensor technology to measure the cognitive and biological function of older adults in their everyday life. These methods could provide more cost-effective, accurate, sensitive and `ecologically valid' measurements of early signs of AD than are currently available through standard laboratory and clinical practices. By improving our ability to measure cognitive function in daily life, this work will set the stage for the next generation of early intervention and prevention studies to slow or prevent cognitive decline and the progression of Alzheimer's and related dementias.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG003949-32
Application #
9085655
Study Section
Special Emphasis Panel (ZAG1-ZIJ-9 (J3))
Project Start
Project End
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
32
Fiscal Year
2016
Total Cost
$413,844
Indirect Cost
$126,379
Name
Albert Einstein College of Medicine, Inc
Department
Type
DUNS #
079783367
City
Bronx
State
NY
Country
United States
Zip Code
10461
Hill, Nikki L; Mogle, Jacqueline (2018) Alzheimer's disease risk factors as mediators of subjective memory impairment and objective memory decline: protocol for a construct-level replication analysis. BMC Geriatr 18:260
Eurelings, Lisa Sm; van Dalen, Jan Willem; Ter Riet, Gerben et al. (2018) Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: a systematic review and meta-analysis of individual participant data. Clin Epidemiol 10:363-379
Scott, Stacey B; Sliwinski, Martin J; Zawadzki, Matthew et al. (2018) A Coordinated Analysis of Variance in Affect in Daily Life. Assessment :1073191118799460
Blumen, Helena M; Brown, Lucy L; Habeck, Christian et al. (2018) Gray matter volume covariance patterns associated with gait speed in older adults: a multi-cohort MRI study. Brain Imaging Behav :
Kidana, Kiwami; Tatebe, Takuya; Ito, Kaori et al. (2018) Loss of kallikrein-related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice. EMBO Mol Med 10:
Sanchez-Contreras, Monica Y; Kouri, Naomi; Cook, Casey N et al. (2018) Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci. Mol Neurodegener 13:37
Kasanuki, Koji; Ross, Owen A; DeTure, Michael A et al. (2018) Relationships between lewy and tau pathologies in 375 consecutive non-Alzheimer's olfactory bulbs. Mov Disord 33:333-334
Ogaki, Kotaro; Martens, Yuka A; Heckman, Michael G et al. (2018) Multiple system atrophy and apolipoprotein E. Mov Disord 33:647-650
Hyun, Jinshil; Sliwinski, Martin J; Almeida, David M et al. (2018) The moderating effects of aging and cognitive abilities on the association between work stress and negative affect. Aging Ment Health 22:611-618
Fleysher, Roman; Lipton, Michael L; Noskin, Olga et al. (2018) White matter structural integrity and transcranial Doppler blood flow pulsatility in normal aging. Magn Reson Imaging 47:97-102

Showing the most recent 10 out of 319 publications